Tuesday, September 29, 2026

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Public Confidence in Measles Vaccine Falls in U.S.

Public Confidence in Measles Vaccine Falls in U.S.

Public confidence in the safety of measles vaccines has declined in the United States, according to a new Reuters/Ipsos poll. The survey found that 76 percent of people in the U.S. consider the measles, mumps and rubella (MMR) vaccine safe for children. That figure was 84 percent in a similar Reuters/Ipsos poll conducted in May […]

Graphene Oxide Being Tested on Animals as an Adjuvant in Vaccines

Graphene Oxide Being Tested on Animals as an Adjuvant in Vaccines

Graphene oxide (GO) is a material made from graphene, a very thin form of carbon, with oxygen added to its structure. Scientists have studied GO for possible medical uses, including its use as an ingredient in vaccines. Other researchers have examined what happens when GO comes into contact with human cells. A review published in […]

Spinal Drug Mix-Up Causes Paralysis in Hospital Surgical Patients

Spinal Drug Mix-Up Causes Paralysis in Hospital Surgical Patients

On Aug. 14, 2026, Ascension Saint Thomas Hospital Midtown in Nashville, Tennessee experienced a pharmacy medication error that severely injured four patients undergoing routine joint replacement surgeries. Medical personnel intended to administer mepivacaine, a standard local spinal anesthetic, to block pain signals during surgical procedures. Instead, pharmacy staff accidentally filled syringes with concentrated potassium phosphate […]

Despite Safety Concerns, FDA Approves Moderna’s mRNA Flu Shot

Despite Safety Concerns, FDA Approves Moderna’s mRNA Flu Shot

On Aug. 5, 2026, the U.S. Food and Drug Administration (FDA) approved Moderna’s seasonal flu shot, mFLUSIVA (mRNA-1010), making it the first messenger RNA platform for seasonal influenza in the United States. The decision permits health care providers to use mRNA technology for annual influenza vaccination in eligible age groups.1 FDA regulators approved mFLUSIVA to […]

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.